Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ventracor raises Aus$34 million for LVAD (left ventricular assist device) development:

This article was originally published in Clinica

Executive Summary

Sydney, Australia firm Ventracor has raised Aus$33.75m (US$21.6m) to help fund trials of its left ventricular assist device (LVAD), VentrAssist. The company, which had existing cash of Aus$10.5m, says the financing will cover the completion of its 10-patient Australian pilot trial and enable it to begin a global pivotal trial in early 2004. The first patient to be implanted with the VentrAssist device received it on June 28 2003 (see Clinica No 1071, p 18) and was discharged on August 19, Ventracor said. A second patient will be implanted shortly, it added.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063426

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel